Recombinant Human Thymosin β4 Attenuates Endotoxemia-Induced ALI and EAE by Suppressing Inflammatory and Oxidative Responses
Biomolecules · 22.05.2026 · 16 (6) · 766
DOI: 10.3390/biom16060766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 22.05.2026. Verfasst von Yumeng Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Institute of Radiation Medicine, Beijing 100850, China. Hauptthemen laut MEDLINE: Endotoxemia, Oxidative Stress, Thymosin, Acute Lung Injury. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key R&D Program of China.
Abstract (Originalsprache)
Endotoxemia represents a life-threatening clinical disorder driven by an aberrant host immune response to pathogenic infection, often resulting in severe multiple organ dysfunction. Among its most devastating complications are acute lung injury (ALI) and endotoxemia-associated encephalopathy (EAE), both of which are associated with elevated mortality and currently lack effective targeted interventions. This study evaluated the therapeutic efficacy and underlying molecular mechanisms of recombinant human thymosin β4 (rhTβ4) in a murine model of lipopolysaccharide (LPS)-induced endotoxemia. Our results showed that treatment with rhTβ4 markedly enhanced survival rates and diminished the systemic overproduction of diverse proinflammatory cytokines and chemokines in endotoxemic mice. These systemic protective actions were achieved through the inhibition of the TLR4/NF-κB signaling cascade, the reduction in M1 macrophage polarization, and the simultaneous alleviation of mitochondrial impairment and oxidative stress. Moreover, rhTβ4 treatment significantly rescued EAE-related cognitive deficits and attenuated neuronal damage, primarily through the suppression of neuroinflammation and microglial overactivation. Integrative transcriptomic profiling and functional assays identified lysophosphatidic acid receptor 3 (LPAR3) as an important contributor, suggesting that rhTβ4 suppresses microglial-mediated neurotoxicity at least in part through LPAR3 downregulation. In conclusion, rhTβ4 confers robust multi-organ protection against endotoxemic injury by orchestrating the inhibition of systemic and central neuroinflammatory cascades, positioning it as a promising candidate for the treatment of endotoxemia-induced ALI and EAE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Institute of Radiation Medicine, Beijing 100850, China.
- Department of Pathology, Chengde Medical University, Chengde 067000, China.
ORCID-Profile: Hongyan Zuo
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key R&D Program of China
Zitieren
APA
Ye, Y., Yang, X., Liu, Y., Zhao, J., Chen, T., Xing, Y., Zuo, H., Hao, Y., & Li, Y. (2026). Recombinant Human Thymosin β4 Attenuates Endotoxemia-Induced ALI and EAE by Suppressing Inflammatory and Oxidative Responses. Biomolecules, 16(6), 766. https://doi.org/10.3390/biom16060766
Vancouver
Ye Y, Yang X, Liu Y, Zhao J, Chen T, Xing Y, et al. Recombinant Human Thymosin β4 Attenuates Endotoxemia-Induced ALI and EAE by Suppressing Inflammatory and Oxidative Responses. Biomolecules. 2026;16(6):766. doi:10.3390/biom16060766
BibTeX
@article{Ye2026,
author = {Ye, Yumeng and Yang, Xuefeng and Liu, Ying and Zhao, Jingshuo and Chen, Tongtong and Xing, Yujie and Zuo, Hongyan and Hao, Yanhui and Li, Yang},
title = {Recombinant Human Thymosin β4 Attenuates Endotoxemia-Induced ALI and EAE by Suppressing Inflammatory and Oxidative Responses},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {6},
pages = {766},
doi = {10.3390/biom16060766}
}
EUVIMED